RTP Mobile Logo

Tuesday, December 5, 2017, San Antonio, Texas, 8:00 PM – 9:45 PM (Central Time)

Data + Perspectives: Clinical Investigators Explore the Emerging Role of PARP Inhibition in the Management of Breast Cancer

Event Details

Location:
San Antonio Marriott Rivercenter
101 Bowie Street
San Antonio, TX 78205
Hotel Phone: (210) 223-1000

Time:
8:00 PM – 9:45 PM (Central Time) — Educational Dinner Meeting

Meeting Room:
Grand Ballroom (3rd Floor)

There is no registration fee for this event. However, preregistration is advised, as seating is limited.

Faculty:
Susan M Domchek, MD
Director, MacDonald Women’s Cancer
Risk Evaluation Center
Executive Director, Basser Center for BRCA
Basser Professor in Oncology
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

Karen A Gelmon, MD
Professor, Medicine
University of British Columbia
Medical Oncologist, BC Cancer Agency
Vancouver Cancer Centre
Head, Division of Medical Oncology
University of British Columbia
Vancouver, Canada

Mark Robson, MD
Clinic Director, Clinical Genetics Service
Associate Attending Physician
Clinical Genetics and Breast Cancer Medicine
Associate Member
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Medical College of Cornell University
New York, New York

Hope S Rugo, MD
Professor of Medicine
Director
Breast Oncology and Clinical Trials Education
University of California, San Francisco
Helen Diller Family
Comprehensive Cancer Center
San Francisco, California

Moderator:
Neil Love, MD
Research To Practice
Miami, Florida



Agenda

Four renowned breast cancer investigators will serve as the faculty for this symposium, which will be divided into 4 topic modules specific to the potential role of PARP inhibitors in the management of breast cancer. Each module will feature discussion of cases from the investigators’ practices, presentation of related research and ongoing trials and moderated panel discussion. Clinician attendees will use networked iPads® to complete a premeeting survey related to the cases and topics being presented, and results will be interspersed throughout each module to foster additional discussion among the faculty. Attendees will also be encouraged to use the iPads to submit their own questions and cases to the faculty.

Full agenda will be made available in the fall.

CE Information

Target Audience:
This activity is intended for medical oncologists, breast cancer surgeons, radiation oncologists and other healthcare professionals involved in the diagnosis and treatment of breast cancer.

Learning Objectives:
At the conclusion of this activity, participants should be able to:

  • Recall available guideline recommendations regarding the indications for BRCA mutation testing for patients diagnosed with breast cancer (BC), and utilize the results of this analysis to inform protocol and nonprotocol treatment decision-making.
  • Understand the biologic rationale for the investigation of PARP inhibition as monotherapy or in combination with other systemic approaches for patients with BC, and use this insight to prioritize clinical trial opportunities for appropriate individuals eligible for participation.
  • Recall emerging Phase III efficacy data with the use of PARP inhibition in patients with metastatic BC harboring a BRCA1/2 mutation, and consider the potential diagnostic and therapeutic implications of these findings on future clinical care.
  • Educate patients regarding the side effects associated with the use of PARP inhibitors, and develop preventive and emergent strategies to reduce or ameliorate these toxicities.
  • Describe mechanisms of acquired tumor resistance to PARP inhibitors, and identify investigational therapeutic opportunities to circumvent this process.

CME Credit Form:
A CME credit form will be given to each participant at the conclusion of the activity.

Accreditation Statement:
Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement:
Research To Practice designates this live activity for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy:
Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess conflicts of interest with faculty, planners and managers of CME/CNE activities. Conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the RTP scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations. Financial disclosures will be provided in meeting course materials.

Supporters:
This live activity is supported by educational grants from AbbVie Inc, AstraZeneca Pharmaceuticals LP, Pfizer Inc and Tesaro Inc.

Location

San Antonio Marriott Rivercenter
101 Bowie Street
San Antonio, TX 78205
Hotel Phone: (210) 223-1000

Meeting Room:
Grand Ballroom (3rd Floor)

Directions:
The Marriott Rivercenter hotel is conveniently located within walking distance (1.5 blocks) of the Henry B Gonzalez Convention Center.

 

Registration

This activity is intended for medical oncologists, breast cancer surgeons, radiation oncologists and other healthcare professionals involved in the diagnosis and treatment of breast cancer.

There is no registration fee for this event. However, preregistration is advised, as seating is limited.

Registration for clinicians in practice

I am a practicing physician, fellow or other healthcare provider involved in the treatment of cancer.

Registration for clinicians in practice »
 
Registration for other/industry professionals*

Please note, a limited number of seats are currently available for nonclinicians on a first come, first served basis.

Registration for other/ industry professionals »

* Individuals employed by for-profit organizations, including financial institutions, biotech or pharmaceutical companies
Registration for groups
If you are registering a group (more than 1 person) for this event, please contact us at Meetings@ResearchToPractice.com or (800) 233-6153.
To ensure seating, please check in at our onsite registration desk at least one half hour prior to the start of the meeting. We cannot guarantee seating after the start of the program.

Meal service will be provided to those who attend the program, based on availability.

Photography and/or video recording may be taken during the educational program by Research To Practice and used in future CME programs.

Research To Practice fully complies with the legal requirements of the ADA. If you are in need of assistance (ie, physical, dietary, et cetera), please contact us prior to the event at (800) 233-6153.

NOTICE: Registration for this event is independent of registration for the SABCS conference.